Anthony DeSoyza Consultant Physician Newcastle

Anthony DeSoyza Consultant Physician Newcastle: Expert in Respiratory Medicine

Anthony DeSoyza Consultant Physician Newcastle leads in respiratory medicine with over 15 years of experience. He specializes in lung diseases and has earned a PhD focusing on lung infections. Working primarily at Freeman Hospital, he also holds a senior lecturer position at Newcastle University. His expertise shapes both clinical practice and groundbreaking research.

Professional Background of Anthony DeSoyza Consultant Physician Newcastle

Professor DeSoyza trained in Scotland before moving to Newcastle, where he has contributed extensively to lung medicine. He completed his specialist training in the North East and continues to advance his field through teaching and patient care. Every Wednesday and Thursday afternoon, he runs dedicated clinics, providing personalized treatment to patients with complex lung conditions.

Leading Lung Trials and Research

As the medical lead for one of the UK’s busiest lung trials units, Anthony DeSoyza Consultant Physician Newcastle plays a critical role in testing new treatments. His research focuses on chronic lung diseases such as bronchiectasis and COPD. Importantly, patient participation in his clinics supports vital research into the underlying causes of these illnesses. This collaboration helps improve outcomes and discover innovative therapies.

Special Interests and Contributions in Respiratory Medicine

Professor DeSoyza’s main interests lie in lung and chest medicine. He concentrates on chronic obstructive pulmonary disease (COPD), including smokers’ lung, chronic bronchitis, and emphysema. Additionally, he manages the largest bronchiectasis clinic in the North, treating recurrent lung infections. His clinical trials and research efforts aim to develop new solutions for these challenging respiratory conditions.

National Leadership and Impact

Beyond his clinical and academic roles, Professor DeSoyza serves as the National Specialty Lead for the Respiratory group of the National Institute for Health Research. His leadership influences respiratory medicine policies and research priorities across the country. Through this work, he ensures patients receive cutting-edge care and access to novel treatments.